Disability Benefits for Thalassemia

How SSA Evaluates Thalassemia

Thalassemia is an inherited blood disorder in which the body makes abnormal or insufficient hemoglobin, causing chronic anemia. Its severity ranges widely: thalassemia minor (trait) usually causes only mild anemia, while thalassemia major (Cooley's anemia) requires lifelong red blood cell transfusions to sustain life. The Social Security Administration evaluates the serious forms under Blue Book listing 7.10, disorders of bone marrow failure, and under listing 7.17 after a stem cell transplant.

Listing 7.10 is met when the disorder requires ongoing, life-sustaining treatment, most clearly shown by:

• Transfusion dependence. A documented need for red blood cell transfusions on average at least once every six weeks to maintain adequate hemoglobin.
• Serious, recurrent complications of the disorder or its treatment, such as severe infections or the effects of iron overload.

Lifelong transfusions bring their own major complication — iron overload — which damages the heart, liver, and endocrine glands and requires iron-removing (chelation) therapy. SSA considers these secondary organ effects as well, evaluating any heart, liver, or hormonal damage under the appropriate body-system listings and weighing everything together. If a bone marrow or stem cell transplant is performed, listing 7.17 provides at least 12 months of disability with later reassessment. The impairment must last at least 12 months.

Medical Evidence SSA Needs for Thalassemia

The diagnosis is confirmed by specialized blood testing, so SSA needs hemoglobin electrophoresis and genetic testing results establishing the type of thalassemia, along with complete blood counts over time showing the chronic anemia. Reticulocyte counts and evidence of the body's response to the anemia help complete the picture.

Because the listing turns on transfusion dependence, transfusion records are the key evidence: dates and frequency establishing whether you need red cells roughly every six weeks. Document chelation therapy for iron overload and, importantly, ferritin levels and any testing of the organs iron damages — cardiac imaging, liver studies, and hormone levels — since organ damage strengthens the claim.

Records of complications such as infections, bone changes, an enlarged spleen, or a splenectomy, and hematology notes summarizing the course, round out the file SSA relies on.

Qualifying Through Your Residual Functional Capacity

People with thalassemia who fall short of the listing — or whose disease is well managed on transfusions but still limiting — are evaluated on residual functional capacity. Chronic anemia causes fatigue, breathlessness on exertion, and reduced stamina that limit lifting, standing, walking, and the ability to sustain physical work, generally pointing toward sedentary activity with rest breaks.

The complications of long-term treatment matter just as much. Iron overload can damage the heart, causing exertional limits, and the liver and endocrine glands, causing fatigue and other systemic effects that reduce reliability. The transfusion schedule itself — a day tied up every few weeks, plus recovery — creates predictable absences, and chelation therapy adds its own burden.

For claimants 50 and older, a sedentary RFC combined with the medical-vocational grid rules often supports approval. Younger claimants generally prevail by showing that fatigue, organ complications, and transfusion-related absences keep them from sustaining even sedentary work.

Tips for a Stronger Thalassemia Claim

Document both the anemia and the toll of lifelong treatment.

• Keep a record of every transfusion with dates; the six-week average in listing 7.10 depends on that history.
• Save your hemoglobin electrophoresis, genetic testing, and blood counts to establish the diagnosis and severity.
• Make sure iron overload and any heart, liver, or hormone damage are documented — those organ effects can strengthen the claim.
• Report fatigue and reduced exercise tolerance concretely so they enter the record.
• Ask your blood doctor to describe how the anemia and treatment schedule limit your daily activity and work reliability.